Course - Update on Bacterial Meningitis: Diagnosis, Surveillance, and Treatment

Course - Update on Bacterial Meningitis: Diagnosis, Surveillance, and Treatment
cover

Virtual Course on Bacterial Meningitis: Diagnosis, Surveillance, and Treatment
Join and participate!


Organizer: Pan American Health Organization/World Health Organization (PAHO/WHO)
Partners and collaborators: CDC, INCIENSA, SE-COMISCA
When: August 5th to 27th | 10 am - 1:30 pm CST/12 - 3:30 pm EST (see schedules per day)
How: Zoom platform
Participant’s registration: register here
Simultaneous interpretation Spanish, Portuguese, English.

 

This course of 5 modules to take place during the month of August 2021 aims to contribute to strengthening the surveillance of meningococcal disease, more specifically, timely clinical and laboratory diagnosis to optimize comprehensive care for patients with meningococcal disease and guide public health measures in Latin America and the Caribbean.

The course is aimed at health professionals including physicians, nurses, microbiologists, epidemiologists, public health specialists, pharmacists with responsibilities or interest in the diagnosis, surveillance, and management of bacterial meningitis in children and adults.

On August 5th, the course begins with Module I: Introduction to Bacterial Meningitis and Epidemiological Situation in Latin American and the Caribbean. Each module will include a case study and module 5, will include a simulacrum on the emergence and dissemination of Nm.
 

FOLLOW ALL LIVE SESSIONS ON YOUTUBE

YouTube

Overview of the course program | Upcoming modules

Module 1. Introduction to Bacterial Meningitis and Epidemiological Situation in Latin America and the Caribbean (see agenda) |
(August 5th, 10 am - 12 pm CST/ 12 - 2 pm EST)

  • Case Study 1. Emergency of N. meningitidis not susceptible to third-generation cephalosporins in Costa Rica, 2019.

Module 2. Diagnosis of Bacterial Meningitis (see agenda)
(August 12th , 10 am -1:30 pm CST/ 12 - 3:30 pm EST)

  • CLINICAL/ Clinical presentation, risk factors, diagnosis and treatment of meningococcal disease
    10:00 -11:30 am CST.

  • ALL/Case Study 2. Outbreaks of N. meningitidis W135 in Chile, 2012.
    11:30 am -12:00 pm CST.

  • LAB/Laboratory Diagnostics
    12:00 - 1:30 pm CST.

Module 3. Differentiation and Characterization of Pathogens that Cause Meningitis. Clinical Management and Prevention and Control Strategies for Nm (see agenda)
(August 19th, 10 am -1:30 pm CST/ 12 - 3:30 pm EST)

  • CLINICAL/Follow-up, prophylaxis, and vaccination
    10:00 -11:30 am CST.

  • ALL/Case Study 3.Use of surveillance data for public health decision-making: introduction of the meningococcal vaccine in Argentina.
    11:30 am -12:00 pm CST.

  • LAB/Serological characterization, molecular diagnosis, and sensitivity tests 
    12:00 - 1:30 pm CST.

Module 4. Epidemiological surveillance of meningitis and challenges in the diagnosis of meningococcemia (see agenda)
(August 26th, 10 am -12 pm CST/ 12 - 2 pm EST)

  • Case Study 4. Challenges in diagnosing a case of meningococcemia.

Module 5. Practical Approach to a Nm Emergency and Public Health Response (see agenda)
(August 27th, 10 am -12 pm CST/ 12 - 2 pm EST)

  • Simulacrum. Emergence and dissemination of beta-lactamase-producing N. meningitidis and resistance to ciprofloxacin in El Salvador and United States.

 

card

 

Read more information

(Spanish only)